Jul 22 – 23, 2026
Heidelberg Congress Center
Europe/Berlin timezone

Session

Poster Session 1.1

Jul 22, 2026, 12:00 PM
Heidelberg Congress Center

Heidelberg Congress Center

Czernyring 20 69115 Heidelberg Germany

Presentation materials

There are no materials yet.

  1. Ms Camila Sanchez Saez (School of Allied Health, Sport and Social Work Griffith University, Queensland, Australia)
    7/22/26, 12:00 PM
    1 - Scientific Poster

    Introduction: Breast cancer-related lymphoedema (BCRL) is a prevalent condition associated with lifelong physical, psychological and social burden, and lower quality of life. The primary aim of this trial is to determine if adding exercise therapy or compression therapy to usual care can prevent BCRL. Secondary aims evaluate effects on patient-reported outcomes and the cost-effectiveness of...

    Go to contribution page
  2. Alice Avancini (University of Verona)
    7/22/26, 12:00 PM
    1 - Scientific Poster

    Introduction. Observational evidence links exercise to longer survival, but to date, no causality has been demonstrated. The primary aim of the STARLighT trial is to evaluate the impact of a structured exercise and nutrition intervention on pathological complete response (pCR) in patients undergoing neoadjuvant treatment and on disease-free survival (DFS) in patients undergoing adjuvant...

    Go to contribution page
  3. Ms Linde Huis in 't Veld (Department of Medical Oncology, Amsterdam UMC location University of Amsterdam, Amsterdam, The Netherlands)
    7/22/26, 12:00 PM
    1 - Scientific Poster

    Background
    Patients with incurable gastroesophageal adenocarcinoma (GAC) experience an impaired health-related quality of life (HRQoL), which might further deteriorate over time. These patients are often confronted with significant life-impacting symptoms, such as fatigue and reduced physical functioning. Exercise combined with nutritional support may improve these outcomes. However,...

    Go to contribution page
  4. Dr Synne-Kristin Hoffart Bøhn (Department of Oncology, Oslo University Hospital)
    7/22/26, 12:00 PM
    1 - Scientific Poster

    Background: Persistent fatigue is a complex and highly distressing late effect after cancer, reported by more than one-third of women treated for breast cancer (BC). Randomized controlled trials (RCTs) investigating the effect of multidisciplinary interventions among cancer survivors with persistent fatigue are lacking. In a recently completed RCT in fatigued lymphoma survivors (the...

    Go to contribution page
  5. Nida Huijben (Division of Psychosocial Research & Epidemiology, The Netherlands Cancer Institute, Amsterdam, Netherlands)
    7/22/26, 12:00 PM
    1 - Scientific Poster

    Background Exercise has been suggested as a promising non-pharmaceutical intervention for cancer treatment induced peripheral neuropathy (CIPN). However, current evidence is limited to only a few, mostly small, studies with heterogeneous interventions and methodological limitations, and only a limited number of studies focus on chronic CIPN. In addition, data on the cost-effectiveness of...

    Go to contribution page
  6. Heather Leach (Colorado State University)
    7/22/26, 12:00 PM
    1 - Scientific Poster

    Background and Purpose: Moderate to vigorous intensity physical activity (MVPA; i.e., aerobic and resistance exercise) improves physical function and quality of life for cancer survivors and is associated with reductions in cancer-specific and all-cause mortality. Unfortunately, recent estimates suggest that only 14% of individuals with a cancer history are engaging in the amount of MVPA...

    Go to contribution page
  7. Baptiste Fournier (Centre Léon Bérard)
    7/22/26, 12:00 PM
    1 - Scientific Poster

    Older adults, who represent nearly half of new cancer diagnoses in France, remain largely underrepresented in phase I trials (<7%). Functional decline and frailty are key barriers to their participation. The primary purpose of the ENERGY study is to determine whether a multimodal intervention combining exercise, nutritional management, and psychological support can improve inclusion and...

    Go to contribution page
  8. Rasmus Døssing (MD, National Center for Cancer Immune Therapy)
    7/22/26, 12:00 PM
    1 - Scientific Poster

    Background:
    Since introduction of immune checkpoint inhibitors, the prognosis of melanoma has improved markedly in both adjuvant and metastatic settings. More recently, neoadjuvant therapy has emerged as an alternative to adjuvant treatment and has shown encouraging clinical and pathological outcomes for patients with melanoma, although long-term survival data are still maturing. Exercise...

    Go to contribution page
  9. Kate Edwards (The University of Sydney), Catherine Seet-Lee (The University of Sydney)
    7/22/26, 12:00 PM
    1 - Scientific Poster

    Background

    Despite strong evidence supporting exercise in cancer care, uptake into routine practice remains low. Exercise during chemotherapy infusion (intra-infusion) offers a novel strategy to address this gap. Exercise could enhance treatment efficacy by acutely increasing tumour blood flow, potentially enhancing drug delivery when performed simultaneously with chemotherapy infusion....

    Go to contribution page
  10. Dr Gunn Ammitzbøll (Danish Research Center for Equality in Cancer, Zealand University Hospital, Department of Clinical Oncology and Palliative Care)
    7/22/26, 12:00 PM
    1 - Scientific Poster

    Introduction
    Research in exercise oncology has consistently provided evidence supporting the integration of exercise into all phases of cancer care but less is known about how this can be implemented across patient groups, geographical borders and health care systems. This study, part of the Interreg South Baltic Program-funded project “AMBeR” (Advanced Modelling of Baltic E-cancer caRe),...

    Go to contribution page
  11. Pedro Ramos (Universidade Lusófona)
    7/22/26, 12:00 PM
    1 - Scientific Poster

    Background. Chemotherapy side effects often cause dose reductions or delays in women with breast cancer (BC), and relative dose intensities below 85% are linked to poorer prognosis and reduced treatment efficacy. Exercise may modulate treatment response by influencing the tumor microenvironment. Recent evidence suggests that exercise may contribute to tumor regression during neoadjuvant...

    Go to contribution page
  12. Dr Ignacio Catala Vilaplana (Department of Physical Therapy, University of British Columbia, Vancouver, Canada)
    7/22/26, 12:00 PM
    1 - Scientific Poster

    The CCTG CO.21 Trial is a large randomized controlled trial that recently improved disease-free survival and overall survival in colon cancer patients after a 3-year structured exercise program. PURPOSE: This sub-study leverages data from the CO.21 Trial to test the effect of the first 12-months of physical activity behaviour change intervention (EG) compared to health-education group (HEG) on...

    Go to contribution page
  13. Nuno Dias Rato (CIDESD - Research Center in Sports Sciences, Health Sciences and Human Development, Portugal ; ONCOMOVE® - Associação de Investigação de Cuidados de Suporte Em Oncologia (AICSO), Portugal)
    7/22/26, 12:00 PM
    1 - Scientific Poster

    Purpose: Improving the effectiveness of breast cancer (BC) treatment remains a major priority due to its high incidence and mortality. Neoadjuvant chemotherapy (NACT) is widely used in triple negative and HER2 positive disease, and in selected luminal HER2 negative cases. Evidence suggests that structured exercise may enhance treatment responses. This RCT aims to: (1) determine whether adding...

    Go to contribution page
  14. Tormod Nilsen (The Norwegian School of Sport Sciences, Norway)
    7/22/26, 12:00 PM
    1 - Scientific Poster

    Background: Our research shows that symptoms of lower-extremity lymphedema are commonly reported in women who have undergone surgery for endometrial cancer. Although previous trials have demonstrated beneficial effects of exercise training on lymphedema among women with breast cancer, the feasibility and efficacy to treat lower-extremity lymphedema in women with gynecological cancer remains...

    Go to contribution page
  15. PATRICIA SHEEHAN (SOUTH EAST TECHNOLOGICAL UNIVERSITY)
    7/22/26, 12:00 PM
    1 - Scientific Poster

    Background
    Exercise is vital in prostate cancer survivorship, yet many men face barriers to traditional programmes, particularly gym-based options that may not align with their preferences. The Danish FC Prostate Cancer initiative, a recreational football model, has shown strong feasibility and acceptability by offering a culturally familiar, male-friendly alternative that supports social...

    Go to contribution page
  16. Dr Lore Dams ((1) Department of Rehabilitation Sciences and Physiotherapy, MOVANT, University of Antwerp Antwerp, Belgium (2) Department of Physical Medicine and Rehabilitation, University Hospitals Leuven, Leuven, Belgium. (3) Pain in Motion International Research Group, Belgium (4) Improving Care for Edema and Oncology Research Group, Belgium)
    7/22/26, 12:00 PM
    1 - Scientific Poster

    Background: Chemotherapy-induced peripheral neuropathy (CIPN) is a common side effect of neurotoxic cancer treatments, primarily affecting sensory and motor functions in hands and feet. CIPN can interfere with daily activities and cancer treatment. Exercise may represent a promising approach to CIPN prevention; however, it is not currently reflected in international guidelines because evidence...

    Go to contribution page
  17. Dr May Grydeland (Department of Physical Performance, Norwegian School of Sports Sciences)
    7/22/26, 12:00 PM
    1 - Scientific Poster

    Background: Lifestyle factors such as physical activity (PA) may help prevent and reduce adverse effects of androgen deprivation therapy (ADT) in men with prostate cancer. Most evidence on PA in this population comes from exercise-based interventions or self-reported measures that primarily capture structured exercise. While exercise can be beneficial, it is not always appealing or feasible...

    Go to contribution page
  18. Emily Curtis (The Royal Marsden NHS Foundation Trust/King's College London)
    7/22/26, 12:00 PM
    1 - Scientific Poster

    In the UK, supervised exercise is recommended by NICE for prostate cancer patients receiving androgen deprivation therapy (ADT); however, engagement in physical activity remains limited. Although high adherence is observed during supervised exercise, it is unclear whether participants maintain activity after supervision. Barriers include treatment-related side-effects and low motivation....

    Go to contribution page
  19. Simon Nørskov Thomsen (Centre for Physical Acticity Research)
    7/22/26, 12:00 PM
    1 - Scientific Poster

    Background: Metastatic colorectal cancer is largely incurable. The primary goal of first-line treatment is to prolong survival while maintaining acceptable levels of health-related quality of life. However, chemotherapy is associated with substantial treatment-related toxicity, and 30–50% of patients with mCRC experience clinically relevant reductions in health-related quality of life during...

    Go to contribution page
  20. Emily C. LaVoy (University of Houston)
    7/22/26, 12:00 PM
    1 - Scientific Poster

    Introduction: Cancer-related fatigue (CRF) disproportionally impacts survivors of adolescent and young adult (YA) brain tumors. CRF is understudied and poorly managed in this population. While exercise training has demonstrated efficacy at improving CRF in adult cancer survivors—potentially by improving cellular energy production and reducing inflammation— it has not been tested in fatigued YA...

    Go to contribution page